Evaluation of ristocetin. Willebrand factor assay and ristocetin induced platelet aggregation

J. D. Olson; W. J. Brockway; D. N. Fass; M. A. Magnuson; E. J. Bowie

doi:10.1093/ajcp/63.2.210

Evaluation of ristocetin. Willebrand factor assay and ristocetin induced platelet aggregation

J. D. Olson, W. J. Brockway, D. N. Fass, M. A. Magnuson, E. J. Bowie

Pathology

Research output: Contribution to journal › Article › peer-review

65 Scopus citations

Abstract

Normal subjects, patients with various bleeding disorders, and patients with von Willebrand's disease were studied. All patients with von Willebrand's disease had decreased levels of ristocetin Willebrand factor (range, 0 to 41%) as compared with all other subjects (range, 79 to 202%). Ristocetin induced platelet aggregation of platelet rich plasma was abnormal in all patients with von Willebrand's disease tested, and it was possible to correct this abnormal response by addition of normal platelet poor plasma. Abnormal ristocetin induced platelet aggregation was seen in patients with intrinsic platelet disorders or, on some occasions, in normal patients who had ingested aspirin. Ristocetin induced platelet aggregation is not diagnostic, but it may be useful as a simple screening test for patients with possible von Willebrand's disease. In conjunction with other tests, the assay for ristocetin Willebrand factor will be useful in diagnosis and evaluation of these patients.

Original language	English (US)
Pages (from-to)	210-218
Number of pages	9
Journal	Unknown Journal
Volume	63
Issue number	2
DOIs	https://doi.org/10.1093/ajcp/63.2.210
State	Published - Jan 1 1975

ASJC Scopus subject areas

Pathology and Forensic Medicine

Access to Document

10.1093/ajcp/63.2.210

Fingerprint Dive into the research topics of 'Evaluation of ristocetin. Willebrand factor assay and ristocetin induced platelet aggregation'. Together they form a unique fingerprint.

Cite this

@article{f2bfbb95bda8438684ecbe0c0b69dfcd,

title = "Evaluation of ristocetin. Willebrand factor assay and ristocetin induced platelet aggregation",

abstract = "Normal subjects, patients with various bleeding disorders, and patients with von Willebrand's disease were studied. All patients with von Willebrand's disease had decreased levels of ristocetin Willebrand factor (range, 0 to 41%) as compared with all other subjects (range, 79 to 202%). Ristocetin induced platelet aggregation of platelet rich plasma was abnormal in all patients with von Willebrand's disease tested, and it was possible to correct this abnormal response by addition of normal platelet poor plasma. Abnormal ristocetin induced platelet aggregation was seen in patients with intrinsic platelet disorders or, on some occasions, in normal patients who had ingested aspirin. Ristocetin induced platelet aggregation is not diagnostic, but it may be useful as a simple screening test for patients with possible von Willebrand's disease. In conjunction with other tests, the assay for ristocetin Willebrand factor will be useful in diagnosis and evaluation of these patients.",

author = "Olson, {J. D.} and Brockway, {W. J.} and Fass, {D. N.} and Magnuson, {M. A.} and Bowie, {E. J.}",

year = "1975",

month = jan,

day = "1",

doi = "10.1093/ajcp/63.2.210",

language = "English (US)",

volume = "63",

pages = "210--218",

journal = "Research in Microbiology",

issn = "0923-2508",

publisher = "Elsevier Masson SAS",

number = "2",

}

TY - JOUR

T1 - Evaluation of ristocetin. Willebrand factor assay and ristocetin induced platelet aggregation

AU - Olson, J. D.

AU - Brockway, W. J.

AU - Fass, D. N.

AU - Magnuson, M. A.

AU - Bowie, E. J.

PY - 1975/1/1

Y1 - 1975/1/1

N2 - Normal subjects, patients with various bleeding disorders, and patients with von Willebrand's disease were studied. All patients with von Willebrand's disease had decreased levels of ristocetin Willebrand factor (range, 0 to 41%) as compared with all other subjects (range, 79 to 202%). Ristocetin induced platelet aggregation of platelet rich plasma was abnormal in all patients with von Willebrand's disease tested, and it was possible to correct this abnormal response by addition of normal platelet poor plasma. Abnormal ristocetin induced platelet aggregation was seen in patients with intrinsic platelet disorders or, on some occasions, in normal patients who had ingested aspirin. Ristocetin induced platelet aggregation is not diagnostic, but it may be useful as a simple screening test for patients with possible von Willebrand's disease. In conjunction with other tests, the assay for ristocetin Willebrand factor will be useful in diagnosis and evaluation of these patients.

AB - Normal subjects, patients with various bleeding disorders, and patients with von Willebrand's disease were studied. All patients with von Willebrand's disease had decreased levels of ristocetin Willebrand factor (range, 0 to 41%) as compared with all other subjects (range, 79 to 202%). Ristocetin induced platelet aggregation of platelet rich plasma was abnormal in all patients with von Willebrand's disease tested, and it was possible to correct this abnormal response by addition of normal platelet poor plasma. Abnormal ristocetin induced platelet aggregation was seen in patients with intrinsic platelet disorders or, on some occasions, in normal patients who had ingested aspirin. Ristocetin induced platelet aggregation is not diagnostic, but it may be useful as a simple screening test for patients with possible von Willebrand's disease. In conjunction with other tests, the assay for ristocetin Willebrand factor will be useful in diagnosis and evaluation of these patients.

UR - http://www.scopus.com/inward/record.url?scp=0016612738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016612738&partnerID=8YFLogxK

U2 - 10.1093/ajcp/63.2.210

DO - 10.1093/ajcp/63.2.210

M3 - Article

C2 - 1078748

AN - SCOPUS:0016612738

VL - 63

SP - 210

EP - 218

JO - Research in Microbiology

JF - Research in Microbiology

SN - 0923-2508

IS - 2

ER -